|
Thiamine Intervention and Coronary Artery Bypass Grafting
RECRUITINGEarly 1Sponsored by University of California, Los Angeles
Actively Recruiting
PhaseEarly 1
SponsorUniversity of California, Los Angeles
Started2024-10-10
Est. completion2026-06-30
Eligibility
Age60 Years – 80 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT06326996
Summary
The purpose of this study is to gain a better understanding of the association between brain changes and cognitive deficits in coronary heart disease (CHD) patients undergoing coronary artery bypass grafting (CABG) and whether a low-cost thiamine intervention can be used to reduce post-CABG cognitive issues in CHD subjects.
Eligibility
Age: 60 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria: * Patients with Coronary Heart Disease (CHD) scheduled for Bypass Grafting (CABG) * Thiamine deficiency before CABG * European System for Cardiac Operative Risk Evaluation II (EuroSCORE II) \>1.5% * Off-pump surgery Exclusion Criteria: * Dementia at baseline \[Montreal Cognitive Assessment (MoCA) \<21 within 5 days before CABG\] * Current in-take of thiamine * Known thiamine allergy * Uncontrolled blood glucose levels * Unable to give consent due to illness * History of hyperlactatemia * Recent (within several years and/or up to the judgment of the PI/co-PIs) cerebral incidents (seizure or head trauma resulting in loss of consciousness and/or concussion) * Stroke * Diagnosed psychiatric diseases (clinical depression, schizophrenia, manic-depression) * Patients with history of alcohol or substance abuse * Acute or chronic infections (tuberculosis, hepatitis, or encephalopathy) * Diagnosed neuro-degenerative diseases (Alzheimer's or Parkinson's disease) * Chronic immunodeficiency (including HIV) * Congenital brain deficits will also be excluded
Conditions3
Coronary Artery Bypass GraftingCoronary Heart DiseaseHeart Disease
Interventions1
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseEarly 1
SponsorUniversity of California, Los Angeles
Started2024-10-10
Est. completion2026-06-30
Eligibility
Age60 Years – 80 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT06326996